Skip to main content


April 07, 2020
Don't miss this special live presentation on Managing Interventional Oncology in the Time of COVID-19, featuring insight by #CIO2020 Course Director, Edward Kim, MD.
February 07, 2019
Results of a phase II trial suggest that image-guided high-dose-rate (HDR) brachytherapy (iBT) may lead to better outcomes than conventional transarterial embolization (cTACE) in treating unresectable hepatocellular carcinoma (HCC).
February 04, 2019
Patients with renal cell carcinoma who were treated with a combination of sorafenib and cryoablation were compared with those who were treated with sorafenib alone.
January 25, 2019
Primary malignant tumors comprise only 1% to 2% of childhood cancers, but alternatives are still needed for patients in whom chemotherapy fails.
January 14, 2019
In patients with cirrhosis who underwent a TIPS procedure, there is a greater risk of mortality linked with early recurrence of overt hepatic encephalopathy.
December 18, 2018
Adjuvant transarterial chemoembolization was associated with improved outcomes in patients with hepatocellular carcinoma and microvascular invasion, but tumor size affected efficacy.
December 17, 2018
A new study showed the long-term results of and patient satisfaction with trapezius ports in breast cancer patients is associated with high overall patient satisfaction, providing a safe and feasible alternative site to chest ports.
December 17, 2018
The introduction of computer assisted targeting solutions and efficient ablation modalities helped one high-volume center achieve excellent reproducible results as well as minimize operator dependency.
December 13, 2018
Artificial intelligence (AI) is the future of clinical data management with the potential to aid in the intersection between complex data and clinical decision making. Given AIs ability to rapidly analyze big data, interventional radiologists can…
December 09, 2018
At the time of percutaneous transhepatic portal vein embolization (PVE), hyperbilirubinemia has no apparent effect on future liver remnant (FLR) hypertrophy, according to a new study.
December 05, 2018
Transcatheter arterial chemoembolization (TACE) combined with apatinib prolonged time to progression and overall survival compared to TACE-alone for Barcelona Clinic Liver Cancer stage C HCC, according to a study published in BMC Cancer.
Back to Top